| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.011 | 1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.011 | 1 |